MedDeviceGuideMedDeviceGuide
Market

European Union

305 articles

EU MDR / IVDR

EU MDR Article 10a: Supply Chain Discontinuation and Shortage Prevention

Learn when manufacturers must report device interruptions under EU MDR Article 10a, who to notify, required data, supply chain flow, and 2026 guidance.

›
EU MDR / IVDR

EU MIR Form 7.3.1 Mandatory Update: What Changed From Version 7.2.1 and How to Prepare

Prepare for EU MIR Form 7.3.1, mandatory from May 1, 2026, including changes from 7.2.1, reportability fields, UDI issuing entity selection, EUDAMED XML, and vigilance updates.

›
EU MDR / IVDR

EU MDR Article 59 National Derogation: CE Marking Exemptions

Practical guide to MDR Article 59 national derogations, including when non-CE-marked devices may be authorized, how reviews work, and manufacturer strategy.

›
EU MDR / IVDR

EU Reference Laboratories for IVDR Class D IVDs: EURL Guide

Guide to EU Reference Laboratories under IVDR Article 100 for Class D IVDs, including rollout, affected categories, performance verification, batch testing, and manufacturer preparation.

›
Sustainability & ESG

Single-Use Device Reprocessing and Medtech Sustainability Guide

Assess single-use device reprocessing, circular economy benefits, hospital savings, carbon reduction, AMDR data, lifecycle evidence, EU MDR controls, and business case.

›
EU MDR / IVDR

EU MDR Technical File Deficiencies: Common NB Nonconformities

Guide to common EU MDR technical file deficiencies in Notified Body review, including clinical evidence gaps, risk management, PMS links, equivalence, and 2026/977 timelines.

›
Regulatory

Medical Device Clinical Trial Diversity: FDA Action Plan Guide

How device sponsors can prepare FDA Diversity Action Plans under FDORA, set enrollment goals, address waiver criteria, and support representative clinical studies.

›
Digital Health & AI

Medical Device AI Bias Testing: Fairness Validation and Documentation

How to test AI-enabled medical devices for demographic bias, validate fairness statistically, document FDA and EU submissions, and monitor post-market performance.

›
Cybersecurity

Medical Device Cybersecurity Incident Response and Breach Reporting

Build a device cybersecurity response plan covering FDA 21 CFR 806, EU MDR vigilance, CISA timelines, containment, patient safety review, and coordinated disclosure.

›
Design Controls

Medical Device Design Verification Test Protocol Guide

Write and execute verification test protocols with clear scope, acceptance criteria, sample size rationale, results, and FDA, EU MDR, and ISO 13485 alignment.

›
Clinical Evidence

Medical Device Clinical Trial Cost: 2026 Budget Breakdown

2026 medical device clinical trial cost guide covering per-patient costs, site fees, CRO budgets, IDE preparation, monitoring, pivotal studies, and cost-saving strategies.

›
Cybersecurity

Medical Device Cybersecurity Patch Management Guide (2026)

Plan regulated cybersecurity patch deployment for fielded devices under EU MDR, FDA Section 524B, and the Cyber Resilience Act, from triage to verified rollout.

›
Design Controls

Human Factors Content for FDA Medical Device Marketing Submissions

Guide to what human factors evidence to include in FDA 510(k), De Novo, or PMA submissions, including HF categories, critical tasks, use-risk analysis, validation testing, and documentation.

›
Regulatory

FDA Patient Preference Information for Medical Devices: 2026 Final Guidance

Guide to FDA Patient Preference Information for medical devices under the 2026 final guidance, including collection methods, validation, regulatory submissions, benefit-risk use, and EU alignment.

›
Digital Health & AI

SaMD Clinical Evaluation: Clinical Evidence for FDA and EU MDR Submissions

Guide to SaMD clinical evaluation, covering valid clinical association, analytical validation, clinical performance, FDA expectations, EU MDR evidence, and real-world data.

›
Manufacturing

Adhesive Bonding Process Validation for Medical Devices: From Variables to IQ/OQ/PQ

How to validate adhesive bonding for medical devices, including ISO 13485 and FDA QMSR requirements, UV and epoxy variables, IQ/OQ/PQ protocols, surface controls, and revalidation triggers.

›
IVD & Diagnostics

Antibody Clone Lock and Lot-to-Lot Bridging for Immunoassay IVD Kits

How to lock antibody clones, manage lot-to-lot bridging studies, and maintain immunoassay IVD performance across manufacturing campaigns under FDA QMSR, ISO 13485, and EU IVDR.

›
Supply Chain

Battery Cell Sourcing for Portable Medical Devices: Supplier Qualification

How to qualify battery suppliers and design medical device battery packs, covering chemistry selection, IEC 62133-2, UN 38.3, BMS controls, traceability, quality agreements, and dual sourcing.

›
Manufacturing

Biological Specimen Sourcing for IVD Development: Serum, Plasma, Matrix

How to source serum, plasma, urine, CSF, and matrix materials for IVD calibrators and controls, covering donor qualification, viral testing, traceability, lot consistency, and regulatory expectations.

›
IVD & Diagnostics

Calibrators and Controls Traceability for IVD Kits

How to establish traceability for IVD calibrators and controls, covering ISO 17511 hierarchy models, reference materials, commutability, uncertainty, value assignment, and regulatory expectations.

›